CanCan Body Composition Study

NCT ID: NCT07305753

Last Updated: 2025-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-10-15

Study Completion Date

2026-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Participants Young Healthy Adults Elderly (People Aged 65 or More)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cross-sectional group

20 young (20-40yo) and 20 older (70+) adults

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being either male or female
* Being an adult \>20 - \<40 or \>70 years of age.
* Having a body weight of less than 440 pounds
* Being willing to comply with the study procedures
* Not having a chronic illness (e.g., diabetes, cancer, etc.)
* Must be willing to have biospecimens and imaging stored for research use

Exclusion Criteria

* Being pregnant, attempting to become pregnant, or breastfeeding
* Having medical implants such as a pacemaker or metal joint replacements
* Having had a mastectomy, breast reduction, or breast implants
* Having hair that cannot fit in a swim cap
* Having a body weight greater than 440 pounds
* Taking medications that alter the body's fluid compartments (ex: diuretics)
* Not willing to have biospecimens and imaging stored for future research use.
Minimum Eligible Age

20 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pennington Biomedical Research Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Steven Heymsfield

Boyd Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Steven B Heymsfield, MD

Role: CONTACT

Phone: 2257632541

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Steven B Heymsfield, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PBRC 00006218

Identifier Type: -

Identifier Source: org_study_id